Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Mar;35(1):48-54.
doi: 10.1097/WAD.0000000000000407.

Dementia Incidence in the Elderly Population of Greece: Results From the HELIAD Study

Affiliations

Dementia Incidence in the Elderly Population of Greece: Results From the HELIAD Study

George S Vlachos et al. Alzheimer Dis Assoc Disord. 2021 Jan-Mar.

Abstract

Objectives: Recently a declining trend in dementia incidence rates has been reported in high-income countries. We investigated dementia incidence in a representative sample of the Greek population in the age group of 65 years and above.

Methods: This research is part of the Hellenic Epidemiological Longitudinal Investigation of Aging and Diet (HELIAD). The incidence cohort consisted of 1072 participants who were reevaluated after a mean period of 3.09 years.

Results: The incidence rate of dementia was 19.0 cases per 1000 person-years (age-standardized and sex-standardized incidence: 25.4/1000 person-years), of which 16.3 per 1000 person-years were attributable to Alzheimer disease. Each additional year of age increased dementia risk by 19.3% and each additional year of education decreased dementia risk by 12.1%. Apolipoprotein E (APOE)-ε4 homozygous participants were 18 times more likely to be diagnosed with dementia. A baseline diagnosis of mild cognitive decline (MCI) resulted in a risk for dementia increased by 3.7 times compared with the cognitively normal; in participants with MCI at baseline, APOE-ε4 carriage increased dementia risk by 4.5 times.

Conclusions: The incidence rate of dementia in people 65 years and above in Greece is generally consistent with recently published rates in Europe and North America. Advancing age, baseline MCI, and APOE-ε4 homozygosity are risk factors, while higher educational attainment seems protective.

PubMed Disclaimer

Conflict of interest statement

N.S. reports grants from the Alzheimer’s Association, the European Social Fund and the Ministry for Health, Greece, during the conduct of the study; also personal fees from Merck Consumer Health, the NIH, EISAI and EISAI Korea, and grants from the European Prevention of Alzheimer’s Dementia Consortium (EPAD) outside the submitted work. M.Y. reports grants from the European Social Fund and Ministry for Health during the conduct of the study. The remaining authors declare no conflicts of interest.

References

    1. Alzheimer’s Disease International. World Alzheimer Report. London, UK: Alzheimer’s Disease International (ADI); 2016.
    1. Banerjee S. The macroeconomics of dementia—will the world economy get Alzheimer’s disease? Arch Med Res. 2012;43:705–709.
    1. Schrijvers EM, Verhaaren BF, Koudstaal PJ, et al. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78:1456–1463.
    1. Satizabal CL, Beiser AS, Chouraki V, et al. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med. 2016;374:523–532.
    1. Tsolaki M, Fountoulakis C, Pavlopoulos I, et al. Prevalence and incidence of Alzheimers disease and other dementing disorders in Pylea, Greece. Am J Alzheimers Dis Other Demen. 1999;14:138–148.

Publication types

Substances